Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Behav Brain Res. 2014 Jul 12;272:286–302. doi: 10.1016/j.bbr.2014.07.012

Fig. 3.

Fig. 3

Normalized peak velocity. Upper panels: superimposed normalized averages from each subject as a function of BLOCK # (placebo group) or CONC (sedative groups). Lower panels: population averages (±SD). Asterisk near top of SD bar: population average value significantly >1. Asterisk near bottom of SD bar: average value significantly <1. Summary table for the placebo group: “Block(n)”: Block # and number of subjects (n) from which we have data; “Norm avg”: population average (±SD and range) of the average normalized measures from each subject at each BLOCK. An asterisk near the average indicates (as the asterisks in the lower panels) value significantly different from 1. The t-value and probability are reported in columns “t-value” and “Prob”. The “>1/<1/~1” columns report the number of subjects with an average normalized value significantly higher than 1 (>1), significantly lower than 1 (<1) or not significantly different from 1 (~1). Identical layout for the three drugs, with BLOCK substituted by CONC.